Cost-effectiveness of direct-acting antiviral regimen ombitasvir/paritaprevir/ritonavir in treatment-naïve and treatment-experienced patients infected with chronic hepatitis C virus genotype 1b in Japan

2016 ◽  
Vol 19 (12) ◽  
pp. 1144-1156 ◽  
Author(s):  
Suchin Virabhak ◽  
Kikuo Yasui ◽  
Kiyotaka Yamazaki ◽  
Scott Johnson ◽  
Dominic Mitchell ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Virus Genotype ◽  
Direct Acting Antiviral ◽  
Chronic Hepatitis C Virus ◽  
Treatment Naïve ◽  
Direct Acting

scholarly journals Effectiveness of sofosbuvir based direct-acting antiviral regimens for chronic hepatitis C virus genotype 6 patients: Real-world experience in Vietnam

PLoS ONE ◽  
2020 ◽  
Vol 15 (5) ◽  
pp. e0233446
Author(s):  
Dung Thanh Nguyen ◽  
Thanh Thi Thanh Tran ◽  
Ngoc My Nghiem ◽  
Phuong Thanh Le ◽  
Quang Minh Vo ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Real World ◽  
Virus Genotype ◽  
Direct Acting Antiviral ◽  
Chronic Hepatitis C Virus ◽  
Direct Acting
Sign in / Sign up

Export Citation Format

Share Document